Home > Insider Trading > Filing (0001562180-22-005251)

Filing Details

Accession Number:: 0001562180-22-005251
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-06-21 18:50:53
Reporting Period:: 2022-06-16

Accepted Time:: 2022-06-21 18:50:53
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1710072	Edgewise Therapeutics Inc.	EWTX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1191702	R John Moore	C/O Edgewise Therapeutics, Inc. 3145 Colorado Ave Boulder CO 80303	General Counsel	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-06-16	14,722	$1.93	17,722	No	4	M	Direct
Common Stock	Disposition	2022-06-16	14,722	$6.17	3,000	No	4	S	Direct
Common Stock	Acquisiton	2022-06-17	22,127	$1.93	25,127	No	4	M	Direct
Common Stock	Disposition	2022-06-17	22,127	$6.62	3,000	No	4	S	Direct
Common Stock	Acquisiton	2022-06-21	13,508	$0.71	16,508	No	4	M	Direct
Common Stock	Acquisiton	2022-06-21	17,570	$1.93	34,078	No	4	M	Direct
Common Stock	Disposition	2022-06-21	31,078	$7.29	3,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2022-06-16	14,722	$0.00	14,722	$1.93
Common Stock	Stock Option (Right to Buy)	Disposition	2022-06-17	22,127	$0.00	22,127	$1.93
Common Stock	Stock Option (Right to Buy)	Disposition	2022-06-21	17,570	$0.00	17,570	$1.93
Common Stock	Stock Option (Right to Buy)	Disposition	2022-06-21	13,508	$0.00	13,508	$0.71

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
181,614	2030-12-15	No	4	M	Direct
159,487	2030-12-15	No	4	M	Direct
141,917	2030-12-15	No	4	M	Direct
121,562	2030-09-01	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on March 16, 2022.
The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.26, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $6.21 to $6.89, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $6.72 to $7.49, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
1/48th of the shares subject to the option vest each month beginning on January 16, 2021, subject to the Reporting Person continuing as a service provider through each vest date.
1/4th of the shares subject to the option became vested and exercisable on September 1, 2021 and 1/48th of the shares subject to the option continue to vest each month, subject to the Reporting Person continuing as a service provider through each vest date.